Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Bioreduction. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111686809A reveals a robust dual-enzyme system for producing chiral statin intermediates, offering enhanced stability and cost-effective manufacturing solutions.
Novel KmAKR mutants enable high-yield enzymatic synthesis of rosuvastatin side chains, offering superior stability and cost-effective manufacturing solutions.